INmune Bio, Inc. ( INMB) - Key Metrics
INMB Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.05 | -$0.12 | -$0.13 |
| 2026Q1 | $0 | -$0.20 | -$0.13 | -$0.13 |
| 2025Q4 | $0 | -$0.20 | -$0.11 | -$0.14 |
| 2025Q3 | $0 | -$0.24 | -$0.20 | -$0.21 |
| 2025Q2 | $0 | -$1.05 | -$0.32 | -$0.35 |
INMB Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -8.15 |
| 2026Q1 | 0% | -1.41 |
| 2025Q4 | 0% | -1.95 |
| 2025Q3 | 0% | -2.16 |
| 2025Q2 | 0% | -0.55 |
INMB
Price: $2.11
52 week price:
Earnings Per Share: -0.60 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 49961
Market Capitalization: 56.6 million